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ABSTRACT  
Context: Cutaneous Vasculitis is the inflammation of vessel walls which leads to hemorrhagic or ischemic events. The histopathological 
classification of cutaneous vasculitis depends on the vessel size and the dominant immune cell mediating the inflammation. Object: We 
studied the etiological factors and clinico-pathological spectrum of patients with cutaneous vasculitis at a tertiary referral centre of north 
India. Design:  Skin biopsies of all patients with clinically suspected cutaneous vasculitis presenting over 5 years, between 2009-2014 
were reviewed. Cutaneous vasculitis was classified on the basis of etiology (primary or secondary), on the basis of size of vessel wall as 
well as on the dominant inflammatory cell infiltrating the vessels. Results: Over 5 years, 62 / 103 patients evaluated for vasculitic 
syndromes had histologically proven vasculitis. Clinically, vasculitis was primary (77.4%) or secondary (22.5%) to drugs, infections, 
underlying connective tissue diseases and malignancy. Neutrophilic (n=30), lymphocytic (n=18), eosinophilic (n=10), and granulomatous 
(n=4) vasculitis were the major histopathological groups. Small vessel involvement was seen in 97% cases. Conclusion: Skin biopsy 
remains the gold standard for diagnosing cutaneous vasculitis. Small vessel vasculitis was the most common type of cutaneous vasculitis 
with the dominant cell type being neutrophilic. Eosinophilic infiltrate was exclusively associated with primary vasculitis. 
KEYWORDS: Cutaneous vasculitis, Small vessel vasculitis, Skin biopsy. 
INTRODUCTION 
Cutaneous vasculitis (CV) is an inflammatory process of the 
vessels leading to the destruction of their wall with subsequent 
hemorrhagic features with or without ischemic necrosis[1]. The 
incidence of cutaneous vasculitis ranges from 15.4 to 29.7 cases 
per million per year[2,3].The condition usually affects adults with 
a slight female predominance, however, all ages may be 
afflicted. CV is classified histo-morphologically on the basis of 
size of vessel affected (small or medium vessel vasculitis) and 
on the basis of the dominant cell mediating inflammation- 
neutrophilic/leukocytoclastic, lymphocytic, eosinophilic and 
granulomatous. On the basis of etiology, they are classified as 
primary/idiopathic or secondary to an underlying cause like 
drug induced, connective tissue disorders, infections, 
malignancy, etc.   
Vasculitis in a medium or large vessel is defined as presence of 
inflammatory cells within their walls, whereas in small vessels 
diapedesis of various leukocytes often take place and this 
criteria alone is not significant. It must be associated with signs 
of vessel damage, such as fibrin within the walls, thrombi or 
endothelial necrosis. Veins are involved more commonly than 
arterioles. Clinically, CV can present with a variety of signs and 
symptoms like urticaria, palpable purpura, ulcers, 
maculopapular rash, nodules, hemorrhagic vesicles, etc. It can 
be limited to skin or manifest in other organs like kidney, lungs 
and heart. Due to this myriad of presentations, CV can mimic a 
variety of other dermatological and systemic diseases. Skin 
biopsy remains the gold standard for diagnosis of cutaneous 
vasculitis complemented by clinical data and relevant 
haematological and immunological investigations. In this 
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article, we will be presenting the histopathological spectrum of 
cutaneous vasculitis at a single centre of north India. 
MATERIALS AND METHODS 
Study design: Retrospective medical record based 
observational study. 
Study locus & period: August 2009 and July 2014 at a single 
tertiary referral centre of north India 
Ethical approval: Approval was obtained from the institute’s 
research committee for compiling the data from the hospital 
records. Since it was a retrospective study, ethical clearance was 
not needed. 
Inclusion criteria: All patients (irrespective of age and sex) 
with a clinical suspicion of cutaneous vasculitis who underwent 
skin biopsy during the study period were included. 
Exclusion criteria: Patients with thrombocytopenia 
(<50,000/cu.mm), those on warfarin therapy and with disorders 
of coagulation were excluded. 
Methodology:  
All biopsies were routinely processed and stained with 
Haematoxylin and Eosin (H&E). Serial sections were taken in 
which no vasculitis was identified on initial section. Elastic 
tissue staining to assess the damage to the elastic lamina in 
muscular vessels was also performed. Simultaneously, a 
hemogram, ESR, kidney and liver functions, rheumatoid factor 
and immunological tests like ANA and ANCA were also carried 
out for assessment. Direct immunoflourescence (DIF) could not 
be undertaken in any case due to lack of infrastructure. 
STATISTICAL ANALYSIS 
The clinical and histopathological data was collected and was 
transformed into a master chart which was then subjected to 
ststistical analysis using chi-square test. The findings were 
arranged in tables using microsoft excel sheet. 
RESULTS 
Over 5 years a total of 480 skin biopsies were studied out of 
which 103 cases were performed in those with clinically 
suspected vasculitis. However, 62 out of these 103 cases were 
histologically confirmed to have vasculitis; the remaining had 
unremarkable and non-specific histologic features. Those with 
positive histological features had a mean age of 44.5 years 
[range 6-83 years] with the male to female ratio of 1.1:1. The 
maximum number of patients (n=15) were seen in the age group 
31-40 years followed by those in the second decade. Clinically 
vasculitis was primary (n=48, 77.4%) or secondary (n=14; 
22.5%). (Table 1)  




Primary  48 (77.4) Neutrophilic (n=22)  
Lymphocytic (n=13) 
Eosinophilic  (n=10) 
Granulomatous (n=3) 
Secondary  14 (22.5)  
Drugs 7 (50) Neutrophilic (n=3)  
Lymphocytic (n=3) 
Eosinophilic  (n=1) 




3 (21.4) Lymphocytic (n=3) 
Malignancy 1 (7.1) Neutrophilic (n=1)  
History of drug intake and presence of recent upper respiratory 
tract infection was seen in 7 and 3 patients respectively. The 
commonest offending drugs were antibiotics of β-lactam group 
and analgesics followed by anti-histaminics. Connective tissue 
disorders (n=3) and malignancy (n=1) were also found to be the 
cause of secondary vasculitis. Clinically palpable purpura was 
the most common finding followed by maculopapular 
rash.(Figure 1). Three-quarters of granulomatous vasculitis 
presented clinically with symptoms of allergic granulomatosis; 
25% (n=4/17) of leukocytoclastic vasculitis presented clinically 
with features of microscopic polyangiitis. Among the 
haematological parameters, a raised ESR was the most 
consistent finding. (Tables 2 & 3). 
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Table 2. Clinical features of cases with histologically 
proven vasculitis 
Clinical feature Number (%) 
Arthralgia/ arthritis 45 (72.5) 
Palpable purpura 34 (54.8) 
Maculopapular rash 18 (29.0) 
Fever 15 (24.1) 
Urticaria 12 (19.3) 
Nodule 4 (6.4) 
Papule 4 (6.4) 
Ulcer 2 (3.2) 
Haematuria 1 (1.6) 
Table 3. Laboratory parameters of patients of patients with 
histologically proven vasculitis 
 Parameter  +ve -ve Not done 
Anemia 12 30 20 
Raised ESR 50  12 
Leukocytosis with neutrophilia 11 31 20 
Eosinophilia 4 38 20 
Thrombocytopenia 8 42 12 
Kidney function tests  4 58 
ANA 12 22 28 
Anti-ds DNA 6 28 28 
ANCA  16 46 
CRP 12 26 24 
Anti HCV  5 57 
ASO titre 8 15 39 
Most of these were small vessel (venules and arterioles) 
vasculitis (n=60, 97%). Only 2 cases showed medium vessel 
vasculitis particularly associated with panniculitis. Depending 
upon the dominant cell mediating inflammation, the dominant 
cell type was neutrophilic (n=30), lymphocytic (n=18), 
eosinophilic (n=10), and granulomatous (n=4). 
Histopathological evaluation in neutrophilic vasculitis showed 
transmural infiltration of vessel wall with neutrophils (Figure 2). 
Fibrinoid necrosis, neutrophilic debris with or without 
extravasated red cells were features of leucocytoclastic 
vasculitis. Lymphocytic vasculitis is shown in Figure 3. 
Epithelioid granulomas were seen surrounding and destroying 
the vessel wall in granulomatous vasculitis with transmural 
vessel wall infiltration by lymphocytes and polymorphs (Figure 
4). Medium vessel vasculitis showed infiltration by neutrophils 
in vessel wall which was associated with septal panniculitis. 
(Figure 4).  










Pustular dermatosis (n=5)  
Microscopic polyangiitis (n=4)  
Rheumatoid vasculitis (n=2) 
Hypersensitivity vasculitis (n=1) 
Erythema Elevatun Diutinum (n=1) 
Henoch-Schonlein Purpura (n=1) 
Lymphocytic 
(n=13) 
Chronic Urticaria (n=4) 
Perniosis (n=3) 
Pityriasis Lichenoides (n=2) 
Atrophie Blanche (n=2) 
Erythema Annulare Centrifugum (n=1) 
Polymorphous Light Eruptions (n=1) 
Eosinophilic 
(n=10) 
Urticarial vasculitis (n=6) 
Prurigo nodularis (n=2) 
Hypersensitivity vasculitis (n=1) 
Granuloma faciale (n=1)  
Granulomatous 
(n=3) 
Allergic granulomatosis (n=2) 
Churg-Strauss Syndrome (n=1) 
  
 
Secondary Small Vessel Vasculitis (n= 12) 
Neutrophilic 
(n=6) 
Drug reaction (n=3) 
Behcet’s disease (n=1) 
Sweets syndrome (n=1) 
Acute neutrophilic dermatosis (n=1) 
Lymphocytic 
(n=5) 
Drug reaction (n=4) 
Discoid lupus erythematosis (n=1) 
Granulomatous 
(n=1) 
Wegener’s granulomatosis (n=1) 
Medium vessel vasculitis (n=2) 
Neutrophilic 
(n=2) 
Polyarteritis Nodosa (n=2) 
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Figure 1. Palpable purpura 
 
Figure 2. H & E (20x10X): Neutrophilic vasculitis 
 
Figure 3. H&E (10x10X): Lymphocytic vasculitis 
 
Figure 4. H&E (20x 10X): Granulomatous vasculitis 
 
Figure 5. H&E (20x10X): Medium vessel vasculitis with 
panniculitis 
Six of the 10 cases with urticarial vasculitis had an eosinophilic 
infiltrate; the remaining showed lymphocytes predominantly. 
Clinically most cases (n=8; 47%) of idiopathic vasculitis were 
of neutrophilic type. Drug reaction was the commonest cause of 
secondary vasculitis (n=7) and most of these (n=4, 57%) showed 
lymphocytic infiltrate (Table 4). 
DISCUSSION  
Cutaneous vasculitis presents as a mosaic of clinical and 
histological findings due to varied pathogenic 
mechanisms[3].Even in the presence of suggestive 
dermatological lesions, biopsy showed histological features in 
nearly 60% cases. We observed primary vasculitic syndromes 
leading to cutaneous histologic changes in 77% of all cases. 
Joint pain and swelling was the main presenting feature, 
palpable purpura and maculopapular rash were the predominant 
clinical cutaneous markers and raised ESR was a consistent 
feature. Mostly small vessels were affected and neutrophils 
predominated in infiltrates. However, there was a substantial 
overlap in the calibre of the vessel, the cellular infiltrate and the 
clinical diagnosis.  
Our observations corroborate with the case series of Carlson et 
al in terms of the dominance of primary vasculitis and lack of 
organ involvement[3]. Raised ESR was also observed by 
Ekenstam et al and Gupta et al[4,5].Arthralgia was the commonest 
systemic manifestation also observed by Gupta et al[5]. Neural 
and renal involvement was seen in 15 (24.1%) and 18 (29%) 
patients respectively in our series. Earlier studies showed 
visceral involvement is seen in <20% of cutaneous vasculitis, 
Int J Clin and Biomed Res. 2015;1(3): 51-56 Page 54 
 
 
Clinico - Histopathological Spectrum of Cutaneous Vasculitis: A Retrospective Study of 62 Cases                                                                              Nadia Shirazi et al. 
with kidney being the most common organ affected[6,7,8]. Fatal 
disease occurs in a minority (<7%) of patients however, we did 
not encounter any mortality in the 1 year follow-up period[3,8].  
Different therapeutic approaches are the main reason for sub-
classifying vasculitis. Avoidance or treatment of the causative 
factor may cure or limit the activity of secondary vasculitis; 
whereas immunosuppressive therapy is the treatment of choice 
for primary vasculitis. Given this broad range of presentations 
of cutaneous vasculitis and the numerous disorders that can 
mimic vasculitis, it is not surprising that it is difficult to correctly 
and confidently classify these patients[9].  Currently the most 
widely adopted vasculitis classification system is that of Chapel 
Hill Consensus Conference (CHCC) which is based on 
pathologic criteria [10]. The other widely used system is that of 
the American College of Rheumatology (ACR) which is based 
on clinical findings[11-18].  As yet, no ideal system of 
classification exists for vasculitis[3,19,20].  
The most accepted classification is one which distinguishes 
between primary and secondary vasculitis, recognizes the 
dominant blood vessel size involved as well as incorporates 
patho-physiological markers such as direct immune-
fluorescence (DIF) and ANCA[21,22].Therefore the classification 
of cutaneous vasculitis into specific syndromes is best first 
approached morphologically by determining vessel size and 
principal inflammatory response[3]. 
This is the first case series classifying cutaneous vasculitis based 
on the vessel calibre and histo-morphologic features from the 
north Indian state of Uttarakhand. Though, the referral centre 
caters to a million people, this data cannot be extrapolated to the 
general population as the people are treated in the periphery by 
practitioners, the data of which is non-existent. A major 
limitation of our study was the non-availability of direct 
immunofluorescence which is considered very important for 
delineating the immunoglubulin type. Nevertheless, since this 
facility is not available in most of the Indian subcontinent and 
there is a lack of expertise in the field of dermatopathology, our 
data merits attention. 
CONCLUSION 
Vasculitis occurs as a primary disorder or secondary to various 
medical conditions, the treatment differing accordingly. The 
severity may range from a self-limited condition to a life 
threatening disorder with multiple organ failure. Skin biopsy is 
an important tool in arriving at a definitive diagnosis duly 
complemented by clinical features, pertinent laboratory data, 
serological evaluation, ANCA with or without direct 
immunofluorescence. 
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